Are Infants and Toddlers with Moderate-to-severe Atopic Dermatitis Undertreated? Experiences of a Finnish Tertiary Care Hospital
DOI:
https://doi.org/10.2340/00015555-3739Abstract
Abstract is missing (Short communication)
Downloads
References
LePoidevin LM, Lee DE, Shi VY. A comparison of international management guidelines for atopic dermatitis. Pediatr Dermatol 2019; 36: 36-65.
DOI: https://doi.org/10.1111/pde.13678
Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol 2018; 32: 657-682.
DOI: https://doi.org/10.1111/jdv.14891
Siegfried EC, Jaworski JC, Kaiser JD, Hebert AA. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. BMC Pediatr 2016; 16: 75.
DOI: https://doi.org/10.1186/s12887-016-0607-9
Perälä M, Ahola M, Mikkola T, Pelkonen AS, Remitz A, Mäkelä MJ. Young children with moderate-to-severe atopic dermatitis can be treated safely and effectively with either topical tacrolimus or mild corticosteroids. Acta Paediatr 2020; 109: 550-556.
DOI: https://doi.org/10.1111/apa.15001
Mandelin JM, Rubins A, Remitz A, Cirule K, Dickinson J, Ho V, et al. Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants: a two-year open-label study. Int J Dermatol 2012; 51: 104-110.
DOI: https://doi.org/10.1111/j.1365-4632.2011.05015.x
van Halewijn KF, Bohnen AM, van den Berg PJ, Pasmans SGMA, Bindels PJE, Elshout G. Different potencies of topical corticosteroids for a better treatment strategy in children with atopic dermatitis (the Rotterdam Eczema study): protocol for an observational cohort study with an embedded randomised open-label controlled trial. BMJ Open 2019; 9: e027239.
DOI: https://doi.org/10.1136/bmjopen-2018-027239
Morley KW, Dinulos JG. Update on topical glucocorticoid use in children. Curr Opin Pediatr 2012; 24: 121-128.
DOI: https://doi.org/10.1097/MOP.0b013e32834ef53d
Dharmage SC, Lowe AJ, Matheson MC, Burgess JA, Allen KJ, Abramson MJ. Atopic dermatitis and the atopic march revisited. Allergy 2014; 69: 17-27.
DOI: https://doi.org/10.1111/all.12268
Moawad S, Mahé E, Aubert-Wastiaux H, Phan A, Maruani A, Chiaverini C, et al. Topical corticosteroid concerns among parents of children with psoriasis versus atopic dermatitis: a French multicenter cross-sectional study. Am J Clin Dermatol 2018; 19: 261-265.
DOI: https://doi.org/10.1007/s40257-017-0318-5
Li AW, Yin ES, Antaya RJ. Topical corticosteroid phobia in atopic dermatitis: a systematic review. JAMA Dermatol 2017; 153: 1036-1042.
DOI: https://doi.org/10.1001/jamadermatol.2017.2437
Bridgman AC, Eshtiaghi P, Cresswell-Melville A, Ramien M, Drucker AM. The burden of moderate to severe atopic dermatitis in Canadian children: a cross-sectional survey. J Cutan Med Surg 2018; 22: 443-444.
DOI: https://doi.org/10.1177/1203475418761859
Yang EJ, Beck KM, Sekhon S, Bhutani T, Koo J. The impact of pediatric atopic dermatitis on families: a review. Pediatr Dermatol 2019; 36: 66-71.
DOI: https://doi.org/10.1111/pde.13727
Castellsague J, Kuiper JG, Pottegård A, Anveden Berglind I, Dedman D, Gutierrez L, et al. A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids. Clin Epidemiol 2018; 10: 299-310.
DOI: https://doi.org/10.2147/CLEP.S146442
Remitz A, Harper J, Rustin M, Goldschmidt WF, Palatsi R, van der Valk PG, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. Acta Derm Venereol 2007; 87: 54-61.
DOI: https://doi.org/10.2340/00015555-0167
Lynde CW, Bergman J, Fiorillo L, Guenther L, Keddy-Grant J, Landells I, et al. Clinical insights about topical treatment of mild-to-moderate pediatric and adult atopic dermatitis. J Cutan Med Surg 2019; 23: 3S-13S.
DOI: https://doi.org/10.1177/1203475419843108
Eichenfield LF, Totri C. Optimizing outcomes for paediatric atopic dermatitis. Br J Dermatol 2014; 170: 31-37.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Andreas Antti, Alexander Salava, Miia Perälä, Anna S. Pelkonen, Mika J. Mäkelä, Anita Remitz
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
